8 Tips BEFORE STARTING GLP-1 Medications for Weight Loss // Dr. G Explains скачать в хорошем качестве

8 Tips BEFORE STARTING GLP-1 Medications for Weight Loss // Dr. G Explains

I cover 8 ESSENTIAL things you need to know BEFORE STARTING GLP1 medications like semaglutide or tirzepatide (Ozempic/Mounjaro) for weight loss without watching this first! I'm Dr G., an internal medicine physician in Hollywood Florida, and I specialize in lifestyle modification coaching and patient education. FREE TDEE Calculator👉https://www.fcmaesthetics.com/tdee 1:1 Consultation with Dr. G👉https://www.floridaconciergemed.com/ GLP-1 Meal Plan Delivery👉https://trifectanutrition.llbyf9.net/... Use Code "DRGLP1" for 40% OFF Your First Order! Dr. Gerard Acloque Jr., MD Hollywood, FL #weightloss #glp1 #glp1forweightloss #semaglutide #tirzepatide Some of the links in this description are affiliate links, which means I may earn a small commission if you make a purchase through them, at no extra cost to you. References 1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Lau, D. C. (2021). Once-weekly semaglutide in adults with overweight or obesity. *New England Journal of Medicine*, 384(11), 989-1002. 2. Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., ... & Lingvay, I. (2019). Effect of subcutaneous semaglutide on body weight in patients with obesity: The STEP 1 randomized clinical trial. *Obesity Reviews*, 20(12), 1997-2018. 3. Davies, M. J., Bergenstal, R., Bode, B., Kushner, R. F., Lewin, A., Skjøth, T. V., ... & Pedersen, S. D. (2015). Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE diabetes randomized clinical trial. *JAMA*, 314(7), 687-699. 4. Holst, J. J. (2019). The physiology of glucagon-like peptide 1. *Physiological Reviews*, 97(2), 725-738. 5. Kushner, R. F., & Kahan, S. (2018). Introduction: The state of obesity in 2018. *Medical Clinics*, 102(1), 1-11. 6. Ryan, D. H., Lingvay, I., Colhoun, H. M., Deanfield, J., García-Pérez, L. E., Jodar, E., ... & Cosentino, F. (2021). Role of obesity in cardiovascular disease. *European Heart Journal Supplements*, 23(Supplement B), B45-B54. 7. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Van Gaal, L. (2021). Effect of continued weekly subcutaneous semaglutide on weight loss in adults with obesity: The STEP 1 trial extension. *The Lancet*, 397(10277), 2146-2155. This channel (Florida Concierge Medicine & Wellness/Dr. Gerard Acloque), its content, and the opinions expressed by Dr. G are intended for informational purposes only and do not constitute medical advice. The content provided on this channel, including videos, comments, and other materials, is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified and trusted health provider with any questions you may have regarding any medical condition. Never disregard professional medical advice or delay in seeking it because of something you have seen or read on this channel. Reliance on any information provided by this channel is solely at your own risk.